Literature DB >> 7053335

Gastric emptying as a determinant of the oral glucose tolerance test.

D G Thompson, D L Wingate, M Thomas, D Harrison.   

Abstract

Intraindividual variation in the results of repeated oral glucose tolerance tests in normal subjects is well recognized but incompletely explained. The present studies show that such variation can be produced by ingestion of the glucose solution during different phases of the normal fasting activity cycle of the upper gut. Such variation is not seen when glucose is administered intraduodenally during the same phases of activity. Gastric emptying shows similar variation with the activity cycle; larger volumes of solution were emptied from the stomach during activity than quiescence, thus presenting greater quantities of glucose solution to the small intestine for absorption. Metoclopramide and hyoscine butylbromide, drugs known to influence the rate of gastric emptying, reduced the variation in the glucose tolerance test. The data suggest na possible use of the glucose tolerance test for the assessment of gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053335

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Dilution of the 75-g oral glucose tolerance test increases postprandial glycemia: implications for diagnostic criteria.

Authors:  J L Sievenpiper; D J Jenkins; R G Josse; V Vuksan
Journal:  CMAJ       Date:  2000-04-04       Impact factor: 8.262

2.  Ileocecal valve as substitute for the missing pyloric sphincter after partial distal gastrectomy.

Authors:  Jürg Metzger; Lukas P Degen; Christoph Beglinger; Martin Siegemund; Wolfgang Studer; Michael Heberer; Felix Harder; Markus O von Flüe
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

3.  Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.

Authors:  Stephanie Sisley; Ruth Gutierrez-Aguilar; Michael Scott; David A D'Alessio; Darleen A Sandoval; Randy J Seeley
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

4.  Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.

Authors:  O Segers; G Somers
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

5.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

6.  Opposite effects of bombesin on insulin and gastrin response to food in humans.

Authors:  C Scarpignato; B Micali
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

7.  Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects.

Authors:  M Horowitz; M A Edelbroek; J M Wishart; J W Straathof
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

8.  Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.

Authors:  M A Nauck; M Büsing; C Orskov; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

9.  Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose.

Authors:  M Nauck; M Büsing; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 10.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.